Abstract
Regulatory barriers prevent widespread availability of cannabis data in the United States (US). As legalization occurs in the US, assessment of consumer/patient population becomes increasingly important, particularly in newly legal states including Massachusetts (MA). Anecdotal and peer-reviewed evidence suggests cannabis effectively treats a variety of symptoms. With high regulatory barriers and a lack of research funding, there is a need to collect cannabis user data outside academically sponsored studies using “citizen science” methods, which have the potential to aggregate shared discovery while educating about cannabis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.